ClinicalTrials.gg
RecruitingNCT07237347PULSEUpdated Aug 26, 2026

Perceptions and Ultrasound Literacy for Sound Volume Management

An observational study in Ultrasound-guided Fluid Management, Volume Responsiveness and Venous Congestion Assessment, sponsored by University Hospital, Basel, Switzerland. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by University Hospital, Basel, Switzerland · Observational

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to assess the knowledge, attitudes, and practices of ICU physicians in Switzerland regarding the use of ultrasound for fluid management and evaluation of venous congestion.

Read the detailed description

This multicenter survey study aims to explore the experiences, perceptions, and attitudes of intensive care unit (ICU) physicians in Switzerland regarding the use of ultrasound for fluid management. The primary objective is to assess participants' knowledge of ultrasound techniques to predict fluid responsiveness and evaluate venous congestion. The study will also compare familiarity with traditional methods (e.g., central venous pressure, IVC-Inferior Vena Cava ultrasound) and newer approaches such as the VEXUS (Venous Excess Ultrasound Score) score or assessment of stroke volume changes during passive leg raise or mini fluid challenges.

Participants will complete an online questionnaire via REDCap, covering demographics, professional background, ultrasound training, knowledge and experience with ultrasound for volume management and venous congestion, as well as institutional factors and suggestions for improvement. The survey will be distributed to physicians working in ICUs at multiple Swiss hospitals, including the University Hospital Basel, Kantonsspital Aarau, Inselspital Bern, Spitalzentrum Biel, and Triemlispital Zürich. Participation is voluntary, and informed consent will be obtained electronically at the start of the questionnaire.

02

Conditions studied

  • Ultrasound-guided Fluid Management
  • Volume Responsiveness
  • Venous Congestion Assessment
  • ICU Physician Practices

Browse trials for

Keywords

  • Ultrasound
  • fluid management
  • volume responsiveness
  • intensive care
03

In context

Hyperemia

98 studies on the registry are indexed under Hyperemia; 44 are open to participants now.

This study's planned enrollment of 200 is above the median of 100 across 46 observational studies indexed under Hyperemia.

Browse Hyperemia studies →

Lead sponsor

University Hospital, Basel, Switzerland is the lead sponsor of 990 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

physicians working in Swiss ICUs

Eligibility criteria

Inclusion Criteria:

  • physicians working in ICUs
  • working in Switzerland
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • ICU staff

    physicians working in ICUs in Switzerland

    Other: Quastionnaire

Interventions

  • OtherQuastionnaire

    physicians working in ICUs will complete a questionnaire through REDcap

06

What researchers measure

Primary outcomes

  1. Physician Knowledge and Experience Using Ultrasound for Fluid Management and Venous Congestion

    The primary outcome is the proportion of ICU physicians in Switzerland who demonstrate knowledge and report regular use of ultrasound techniques for assessing fluid responsiveness and venous congestion, including traditional methods and newer approaches. Data will be collected through a structured online questionnaire.

    Time frame: completion of questionnaire once within the assessement period, takes about 30 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07237347
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Oct 1, 2025
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Aug 26, 2026

Study contacts

Gregor Loosen, MD
Contact
gregormichael.loosen@usb.ch
+41 61 55 65194
Sebastian Berger, MD
Contact
sebastian.berger@usb.ch
+41 61 32 84085
Gregor Loosen, MD
principal investigator · University Hospital of Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion